🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This prospective，multi-center，open-label, controlled study will evaluate th...
Status
Unknown
Location
Department of Hematology, Peking University Third Hospital, Beijing, China
Start Date
2020-07-29
Trial ID
NCT04480099
This study is to investigate the strategy of biomarker guided treatment in ...
Status
Unknown
Location
Ruijin hospital
Start Date
2019-07-17
Trial ID
NCT04025593
Acute myelocytic leukemia ( AML) is a highly heterogeneous group of maligna...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2018-01-01
Trial ID
NCT03453255
Treatments Being Tested
This open-label, multi-cohorts, phase 1/2 study has the primary objective o...
Status
Unknown
Location
Biotherapeutic Department of Chinese PLA General Hospital
Start Date
2020-09-09
Trial ID
NCT04553393
This is a Phase I/II clinical trial for patients with r/r Non-Hodgkin's Lym...
Status
Unknown
Location
Biotherapeutic Department of Chinese PLA General Hospital
Start Date
2020-04-04
Trial ID
NCT04337606
Treatments Being Tested
Evaluate the efficacy and safety of C Pola R-CHP+X compared to CR-CHOP in t...
Status
Not Yet Recruiting
Location
No. 197 Ruijin 2nd Road, Huangpu District, Shanghai, Shanghai, Shanghai
Start Date
2026-03-31
Trial ID
NCT07511114
Treatments Being Tested
Despite advances in understanding the complexities of acute myeloid leukaem...
Status
Unknown
Location
China PLA General Hospital
Start Date
2016-06
Trial ID
NCT02886559
Treatments Being Tested
The prognosis for patients with relapsed/refractory classical Hodgkin lymph...
Status
Not Yet Recruiting
Location
Biotherapeutic Department and Hematology Department of Chinese PLA General Hospital
Start Date
2024-09-01
Trial ID
NCT06563778
This study is to investigate the therapeutic efficacy and side effect of ch...
Status
Completed
Location
The First Affliated Hospital of Soochow University
Start Date
2018-01-01
Trial ID
NCT03985007
Treatments Being Tested
This is a Phase II clinical trial for Decitabine plus Camrelizumab resistan...
Status
Unknown
Location
Biotherapeutic Department of Chinese PLA General Hospital
Start Date
2020-02-02
Trial ID
NCT04233294
Treatments Being Tested